Biliary stem cells in health and cholangiopathies and cholangiocarcinoma

Curr Opin Gastroenterol. 2024 Mar 1;40(2):92-98. doi: 10.1097/MOG.0000000000001005. Epub 2024 Feb 8.

Abstract

Purpose of review: This review discusses evidence regarding progenitor populations of the biliary tree in the tissue regeneration and homeostasis, and the pathobiology of cholangiopathies and malignancies.

Recent findings: In embryogenesis biliary multipotent progenitor subpopulation contributes cells not only to the pancreas and gall bladder but also to the liver. Cells equipped with a constellation of markers suggestive of the primitive endodermal phenotype exist in the peribiliary glands, the bile duct glands, of the intra- and extrahepatic bile ducts. These cells are able to be isolated and cultured easily, which demonstrates the persistence of a stable phenotype during in vitro expansion, the ability to self-renew in vitro, and the ability to differentiate between hepatocyte and biliary and pancreatic islet fates.

Summary: In normal human livers, stem/progenitors cells are mostly restricted in two distinct niches, which are the bile ductules/canals of Hering and the peribiliary glands (PBGs) present inside the wall of large intrahepatic bile ducts. The existence of a network of stem/progenitor cell niches within the liver and along the entire biliary tree inform a patho-biological-based translational approach to biliary diseases and cholangiocarcinoma since it poses the basis to understand biliary regeneration after extensive or chronic injuries and progression to fibrosis and cancer.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bile Duct Neoplasms*
  • Bile Ducts, Intrahepatic
  • Biliary Tract*
  • Cholangiocarcinoma*
  • Humans
  • Stem Cells